Phase i pharmacokinetic and pharmacodynamic study of the pan-PI3K/mTORC vascular targeted pro-drug SF1126 in patients with advanced solid tumours and B-cell malignancies

D. Mahadevan, E. G. Chiorean, W. B. Harris, D. D. Von Hoff, A. Stejskal-Barnett, W. Qi, S. P. Anthony, A. E. Younger, D. M. Rensvold, F. Cordova, C. F. Shelton, M. D. Becker, J. R. Garlich, D. L. Durden, R. K. Ramanathan

Research output: Contribution to journal › Article › peer-review